Log In or Create Account
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact
Advanced Search
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
HIV Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Resources for Fellows and Others New to the HIV Field
On-Demand Webinars for Fellows
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Discrimination and Harassment Policy
Governance
Suggestions and Recommendations from San Francisco Locals
FAQs
Menu
Professors
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Jonathan Koff, MD
Yale University
New Haven, CT, USA
Paul Kirchberger, PhD
Oklahoma State University
Stillwater, OK, USA
Erica Hartmann, PhD
Northwestern University
Evanston, IL, USA
Nikhil George, MD
Harvard Medical School
Cambridge, MA, USA
David Gally, PhD
University of Edinburgh
Edinburgh, Scotland
Tristan Ferry, MD, PhD
Hospices Civils De Lyon
Lyon, France
Breck Duerkop, PhD
University of Colorado, Anschutz Medical Campus
Aurora CO, USA
Laurent Debarbieux, PhD
Institut Pasteur
Paris, France
Alan Davidson, PhD
University of Toronto
Toronto, Canada
Martha R. J. Clokie, PhD
University of Leicester
Leicester, United Kingdom
Page 2 of 38
«
1
2
3
4
5
...
10
20
30
...
»
Last »
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues: Emerging Infections and Health Threats
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
HIV Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Resources for Fellows and Others New to the HIV Field
On-Demand Webinars for Fellows
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Discrimination and Harassment Policy
Governance
Suggestions and Recommendations from San Francisco Locals
FAQs
Practice Question of the Week
November 10, 2025: Drug-Drug Interactions in People With HIV Undergoing Solid Organ Transplantation
In a patient with HIV planning to undergo solid organ transplantation, which of the following antiretroviral therapy regimens should be changed prior to transplant?
A. Bictegravir/tenofovir alafenamide/emtricitabine
B. Darunavir/cobicistat/tenofovir alafenamide/emtricitabine
C. Dolutegravir/rilpivirine
D. Maraviroc/dolutegravir/lamivudine
Register for the Webinar
View Archived Questions
Leave Feedback
Subscribe
CLOSE